REPORT ID 79

Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report Forecast 2017-2021

Publish Date
11-Dec-17
Pages
116
Format
Electronic (PDF)

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape. 

The study is a source of reliable data on:
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Bayer (DE)
Novacap (FR)
Abbott
Pfizer Inc
Geri-Care Pharmaceuticals
Perrigo Company
Kopran Ltd.
Merck Sharp & Dohme Corp.
Sun Pharmaceutical Industries Ltd
...

Product Segment Analysis:
Type 1
Type 2
Type 3 

Application Segment Analysis:
Application 1
Application 2
Application 3 

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth 
It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
It provides distinctive graphics and exemplified analysis of major market segments 
			   
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report Forecast 2017-2021

1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2 Classification of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Application of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.3.2 Application 1 
1.3.3 Application 2
1.3.4 Application 3
1.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Market States Status and Prospect (2012-2021) by Regions
1.4.1 United States
1.4.2 China
1.4.3 Europe
1.4.4 Japan
1.5 Global Market Size of Non-steroidal Anti-inflammatory Drugs (NSAID) (2012-2021)
1.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2021)
1.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2021)

2 Global Economic Impact on Non-steroidal Anti-inflammatory Drugs (NSAID) Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Cost Analysis
3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis
3.1.1 Key Raw Materials
3.1.2 Price Trend of Key Raw Materials
3.1.3 Key Suppliers of Raw Materials
3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
3.2.1 Raw Materials
3.2.2 Labor Cost
3.2.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)

4 Industrial Chain, Sourcing Strategy and Downstream Buyers
4.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Non-steroidal Anti-inflammatory Drugs (NSAID) Major Manufacturers in 2015
4.4 Downstream Buyers

5 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Competition by Manufacturers, Type and Application
5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competition by Manufacturers
5.1.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share of Key Manufacturers (2012-2017)
5.1.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Share by Manufacturers (2012-2017)
5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume and Value) by Type
5.5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type (2012-2017)
5.5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2012-2017)
5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume and Value) by Regions
5.3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Regions (2012-2017)
5.3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Regions (2012-2017)
5.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume) by Application

6 United States Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume, Value and Sales Price)
6.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2012-2017)
6.1.1 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
6.1.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
6.1.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
6.2 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
6.3 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
6.4 United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application

7 China Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume, Value and Sales Price)
7.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2012-2017)
7.1.1 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
7.1.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
7.1.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
7.2 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
7.3 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
7.4 China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application

8 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume, Value and Sales Price)
8.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2012-2017)
8.1.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
8.1.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
8.1.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
8.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
8.3 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
8.4 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application

9 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume, Value and Sales Price)
9.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Value (2012-2017)
9.1.1 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2012-2017)
9.1.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2012-2017)
9.1.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Price Trend (2012-2017)
9.2 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Manufacturers
9.3 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type
9.4 Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application

10 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Analysis
10.1 Bayer (DE)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Product Type, Application and Specification
10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Business Overview
10.2 Novacap (FR)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Product Type, Application and Specification
10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Business Overview
10.3 Abbott
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Product Type, Application and Specification
10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Business Overview
10.4 Pfizer Inc
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Product Type, Application and Specification
10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Business Overview
10.5 Geri-Care Pharmaceuticals
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Product Type, Application and Specification
10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Business Overview
10.6 Perrigo Company
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Product Type, Application and Specification
10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Business Overview
10.7 Kopran Ltd.
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Product Type, Application and Specification
10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Business Overview
10.8 Merck Sharp & Dohme Corp.
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Product Type, Application and Specification
10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Business Overview
10.9 Sun Pharmaceutical Industries Ltd
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Product Type, Application and Specification
10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Business Overview
...

11 Marketing Strategy Analysis, Distributors/Traders
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
11.2.1 Pricing Strategy
11.2.2 Brand Strategy
11.2.3 Target Client
11.3 Distributors/Traders List

12 Market Effect Factors Analysis
12.1 Technology Progress/Risk
12.1.1 Substitutes Threat
12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast (2017-2021)
13.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue Forecast (2017-2021)
13.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Regions (2017-2021)
13.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Type (2017-2021)
13.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Forecast by Application (2017-2021)

14 Appendix